magnolol has been researched along with Seizures in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebrahimi, SN; Hamburger, M; Moradi-Afrapoli, F; Smiesko, M | 1 |
Chen, CR; Huang, ZL; Qu, WM; Tan, R; Urade, Y; Wang, Y; Wu, Z | 1 |
Chan, MH; Chen, HH; Ko, CH; Lin, YR | 1 |
3 other study(ies) available for magnolol and Seizures
Article | Year |
---|---|
HPLC-Based Activity Profiling for GABA
Topics: Animals; Blood-Brain Barrier; Molecular Structure; Pentylenetetrazole; Plant Extracts; Plant Roots; Receptors, GABA-A; Seizures; Valerian; Xenopus laevis; Zebrafish | 2017 |
Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice.
Topics: Animals; Anticonvulsants; Behavior, Animal; Biphenyl Compounds; Cerebral Cortex; Dose-Response Relationship, Drug; Electroencephalography; Excitatory Postsynaptic Potentials; Hippocampus; Lignans; Magnolia; Male; Mice; Mice, Inbred Strains; Molecular Structure; Plant Bark; Receptors, GABA-A; Seizures | 2011 |
Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Biphenyl Compounds; Calcium; Cells, Cultured; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ion Channels; Lignans; Mice; N-Methylaspartate; Neurons; Platelet Aggregation Inhibitors; Potassium Chloride; Quinoxalines; Rats; Rats, Sprague-Dawley; Seizures; Sodium | 2005 |